Hims & Hers Faces FTC Lawsuit Over Customer Privacy Violations
In a significant development, the U.S. online pharmacy Hims & Hers has come under fire from the Federal Trade Commission (FTC), which filed a lawsuit against the company on Wednesday. This announcement, made via a press release from the FTC, highlights serious allegations regarding the mishandling of sensitive customer information.
The FTC charges Hims & Hers with sharing private health data with advertising platforms such as Meta and Snap, the parent company of Snapchat. This troubling breach comes despite the company’s assurances to safeguard its customers’ privacy.
Moreover, Hims & Hers is accused of deceptive practices related to its payment and cancellation policies, making it unduly difficult for consumers to end their subscriptions. These actions have drawn significant ire from customers, prompting a wave of complaints.
The relationship between Hims & Hers and pharmaceutical giant Novo Nordisk has been fraught with tension. Until March of this year, Hims & Hers was selling unlicensed versions of Novo Nordisk’s medications. In a prior legal tussle, Novo Nordisk had filed a lawsuit to halt the sale of its weight loss and diabetes drugs, only to later withdraw the suit in favor of a collaborative partnership. Currently, Hims & Hers sells Novo Nordisk’s products through its platforms.
The FTC’s complaint underscores a concerning reality: consumers are being unwittingly locked into ongoing subscriptions, while their most sensitive information is being disseminated to third parties without their explicit consent. Christopher Mufarrige, director of the FTC’s Division of Consumer Protection, expressed alarm at the situation, stating, “The FTC’s complaint paints a troubling picture.”
As this legal battle unfolds, both the implications for Hims & Hers and the wider ramifications for consumer privacy in the digital age remain to be seen.
